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It has been shown that acute administration of IL-1 
(10, 22, 30) or TNF (2, 24, 30) activates the HPA axis in
Synergism between IL-10 and TNF-« on the activity of the mice and rats, as manifested by increased levels of
pituitap-a rena axis and on food intake oi rats. Am. J. adrenocorticotropic hormone (ACTH) and corticoste-
Phystol. 268 (Endocrinol. Metab. 31): E551-E557,1995.—We n  i o  j o  j  i j ,  ,  ,
investigated the effects of separate and combined intraperito- (B)' Del ^ an? ® fedornv^ y !4) demonstrated that
neal administration for 3 days of recombinant human inter leu- 1S potent than IINr in increasing plasma
kin-1(3 (IL-1) and recombinant human tumor necrosis factor-« levels of ACTH and B in rats when administered acutely.
(TNF) on plasma adrenocorticotropic hormone (ACTH) and There are only a few studies on the effects of chronic
corticosterone (B) levels, adrenal weight, food intake, and administration of IL-1 and TNF on the activity of the
rectal temperature. Eats were equipped with a jugular cannula HPA axis (8, 16). In the studies from our laboratory, it
for daily blood sampling and with an intraperitoneally im- was shown that continuous infusion of IL-1 (2 and 4
planted Alzet osmotic minipump loaded with either saline, 
IL-1 (2.0 (jig/day), TNF (0.2, 2.0, or 10.0 |xg/day), or IL-1 in 
combination with TNF. Plasma ACTH and B levels and 
adrenal weight were significantly increased, in a dose-
(xg/day for 7 days) induced a sustained and dose- 
dependent stimulation of the HPA axis throughout the 
infusion period (28), whereas continuous administra-
dependent way, by simultaneous infusion of IL-l’and TNF but t i ° n  o f in a dose of 4 ng/day for 7 days did not affect
not by administration of either cytokine alone. Chronic admin- plasma B levels (30).
istration of IL-1 alone induced a significant decrease in food Many types of cells express receptors for IL-1 and
intake and a significant elevation of rectal temperature, TNF, but both types of receptors have different mecha
whereas infusion of only the highest dose of TNF significantly nisms for signal transduction. Therefore the effects of
elevated rectal temperature. Coinfusion of IL-1 and TNF these two cytokines may be additive or synergistic (3).
induced both effects in a dose-dependent and synergistic way. Waage and Espevik (32) dem onstrated th a t  IL-1 potenti-
Our data show that simultaneous infusion of IL-1 and TNF in ates th e  lethal effect of TNj? in mice, and synergistic
rate has synergistic effect on the activity of the pituitary- effects Qf and TNp Qn m usde proteolysia (7) and on
adrenal axis as well as on food intake and rectal temperature. 
The existence of two pathways, which act synergistically, may
in crease
plasma ACTH levels (19) were found after coadministra-
the' h^t“to«¡¿o^Tto''''subtle ^  of these, cytokines to rats. Okusawa et al (17)
demonstrated m rabbits that the combination of IL-1
interleukin-1; tumor necrosis factor; hypothalamic-pituitary- 
adrenal axis; food consumption; body temperature
ACTIVATION OF THE IMMUNE
and TNF was more potent in inducing hemodynamic 
and hematological changes typical of septic shock than 
either agent alone. In contrast, Gelin et al. (9) failed to 
show synergism between IL-1 and TNF in stimulating 
the HPA axis. Moreover, Long et al. (13) found that, 
during bacterial although both IL-1 and TNF are capable of causing fever 
infections is accompanied by stimulation of the hypotha- when injected into rats, administration of TNF attenu-
lamic-pituitary-adrenal axis (HPA axis), and there is ates fever due to injection of IL-1, suggesting antago­
nism between IL-1 and TNF. Very recently, Mehta et al.
(15) showed that low doses of IL-1 and TNF individually
stimulate insulin release but in combination cause
suppression of insulin release by rat pancreatic (3-cells in
vitro.
In the light of these controversial data, we investi­
gated in the present study the effects of 3 days continu­
ous infusion of IL-1 and TNF, separately or in combina­
tion, on the activity of the HPA axis. Plasma ACTH and
increasing e oxm is respon-
sible for the stimulation of both the immune s
axis during such conditions 
activation of the HPA axis by endotoxin
mediated by proinflammatory cytokines, especially inter­
leukin-1 (IL-1; see Ref. 21) and tumor necrosis factor 
(TNF; see Ref. 19). It is thought that these cytokines are 
also important mediators of other biological effects of 
endotoxin, including the induction of anorexia, fever, 
and the acute phase response. Despite these similarities, B levels were measured daily. In addition, we investi-
and TNF share no structural homology
both
kine * . / r -  ' r . '  -  . . .  _  _
and manv cells express both IL-1 and
gated the effects of the treatments on adrenal weight, 
daily body weight change, food and fluid intake, and 
rectal temperature. We show that IL-1 and TNF, when 
infused simultaneously into rats, synergize to stimulate
tors, which may contribute to their overlapping biologi- the HPA axis and to induce dose-dependent changes in 
cal activities (3). body weight, food consumption, and rectal temperature.
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METHODS
Materials. Recombinant human (rh) IL-lß was kindly pro­
vided by Dr. R. C. Newton (Du Pont Pharmaceuticals, Wilming­
ton, DE). The preparation was supplied in sterile Dulbecco’s 
phosphate-buffered saline, and endotoxin contamination was 
negligible (< 1 endotoxin unit lipopolysaccharides/mg IL-1).
Human TNF-a produced by recombinant DNA technology 
in Escherichia coli was obtained from Genentech (San Fran­
cisco, CA) through the courtesy of Dr. G. Adolf, Ernst- 
Boehringer-Institut für Arzneimittelforschung (Vienna, Aus­
tria). The specific activity of the preparation was 6 x 107 U/mg 
protein on murine L-M cells. The preparation (lot K 9011AX) 
was supplied in 10 mM sodium phosphate and 200 mM sodium 
chloride (pH 7). According to the specifications of the suppli­
ers, endotoxin contamination was negligible (< 1.2 ng/mg 
protein, as detected in the limulus amoebocyte lysate assay).
Both IL-1 and TNF were diluted to the desired concentra­
tion in sterile pyrogen-free saline just before use. All chemicals 
used were of analytical grade.
Animals. Male albino Wistar rats (Cpb:WU, 10-12 wk old, 
200—220 g) were obtained from the local breeding facility. The 
animals were individually housed in Plexiglas cages in an 
artificially lighted room (lights on at 0700; lights off at 1900). 
Rats were provided commercial rat chow (RMH-TM; Hope 
Farms, Woerden, The Netherlands) and tap water ad libitum. 
Room temperature was 23.1 ± 0.2°C.
Experimental procedures. To diminish the stress by the 
experimental procedures, the animals were handled daily by 
the experimentator, starting 1 wk before cannulation. Blood 
was collected from freely moving rats by means of a chronic 
cannula. Rats were cannulated according to the method 
described by Steffens (26), with some minor modifications, as 
described earlier (29). Briefly, under Hypnorm (0.5 ml/kg body 
wt im; 10 mg/ml fluanisone and 0.315 mg/ml phentanyl 
citrate; Janssen Pharmaceutica, Tilburg, The Netherlands)- 
Dormicum (1.0 ml/kg body wt ip; 5.0 mg/ml midazolam 
hydrochloride; Hoffmann-La Roche, Mijdrecht, The Nether- 
lands)-atropine (0.025 mg/rat sc; Pharmachemie, Haarlem, 
The Netherlands) anesthesia, a Silastic cannula (ID 0.5 mm; 
OD 0.94 mm; Dow Corning, Midland, MI) was inserted into 
the right external jugular vein and passed down to the atrium. 
The distal end of the cannula was tunneled subcutaneously 
and exteriorized through a stab wound on the skin of the head, 
where it was connected to a hooked stainless steel tube. This 
assembly was anchored to the skull with three stainless steel 
screws and acrylic cement. During cannulation, rats were 
continuously exposed to a gas flow of O2-N2O (each 500 
ml/min). To keep the cannula patent, it was filled with a 0.9% 
NaCl solution containing heparin (500 IU/ml; Organon 
Teknika, Boxtel, The Netherlands) and polyvinylpyrrolidone 
(1 g/ml; Merck, Darmstadt, Germany).
Seven or eight days after cannulation, rats were equipped 
with intraperitoneally implanted osmotic minipumps (1 (xl/h 
for 3 days, model 1003D; Alzet, Palo Alto, CA), which were 
loaded with either sterile pyrogen-free physiological saline or 
saline containing IL-1, TNF, or IL-1 in combination with TNF. 
After loading, the pumps were equilibrated and immersed in 
saline at 37°C for 3-4  h according to the instructions of the 
manufacturer. The pumps were implanted intraperitoneally 
under halothane (ICI Pharmaceuticals, Macclesfield, UKJ-CV 
N20  anesthesia between 1430 and 1630. The indwelling 
cannula and the osmotic minipumps were tolerated well by the 
animals, with no signs of discomfort or infection.
Protocol. A total of eight groups of rats was continuously 
infused with saline, IL-1, TNF, or with a combination of IL-1 
and TNF. One group of rats was infused with 2.0 (xg IL-1/day
(1 |xg IL-1 * 57 pmol IL-1). TNF was infused at a rate of 0.2, 
2.0, or 10.0 |xg/day. Three other groups were infused with IL-1 
(2.0 (xg/day) in combination with TNF at a dose of 0 .2 , 2.0, or 
10.0 ng/day (1 |xg TNF « 57 pmol TNF). A control group of 
rats received osmotic pumps filled with 0.9% (wt/vol) NaCl 
solution. Each group consisted of 6-9 rats.
Food and water intake was estimated daily between 0815 
and 0900 by weighing the residual food pellets and water for 
individual cages. Body weight was measured daily at about the 
same time (0815-0900), and daily body weight changes were 
calculated by subtracting the values measured on subsequent 
days. Body temperature was measured two times a day 
between 0815 and 0900 and between 1230 and 1430 in 
conscious hand-held rats by insertion of a thermal probe into 
the rectum. The probe was connected to a digital temperature 
monitor (Digital DT100; Elbatron, Kerkdriel, The Nether­
lands). The mean daily rectal temperature for each rat was 
determined by averaging the morning and afternoon rectal 
temperatures. At the end of the experiment (day 3) rats were 
killed by decapitation, and the adrenals were removed, freed of 
fat, and weighed.
Blood sampling. Blood was collected once a day from freely 
moving rats for 5 days starting 1 day before implantation of 
the minipumps (day — 1 up to and including day 3). Because of 
the circadian rhythm in hormone release, blood was with­
drawn from the animals every day at about the same time 
(between 1000 and 1200). Blood samples (1.8 ml) for measure­
ment of plasma levels of ACTH and B were collected on ice in 
prechilled tubes containing EDTA [45 (xl of a 10% (wt/vol) 
EDTA solution in saline]. The samples were gently shaken and 
spun for 10 min at 1,500 g  (4°C). Plasma was separated, and 
red blood cells were resuspended in sterile physiological saline 
(1.3 ml) and returned to each rat. Plasma samples were stored 
at - 20°C in aliquots of 250 |xl to which 60 kallikrein inhibitory 
units aprotinin (Bayer, Leverkusen, Germany) were added.
Hormone measurements. Plasma ACTH and B values were 
measured by radioimmunoassay, as described by Sweep et al. 
(28). In the group of rats infused with saline alone and in the 
group infused with IL-1 in combination with 0.2 |xg TNF/day, 
one rat had to be excluded with respect to hormone measure­
ments because of blood clotting in the jugular cannula.
Statistical analysis. All data are presented as means ± SE of 
6-9 rats/group. The effect of infusion of IL-1 in combination 
with TNF is considered to be synergistic if the effect of 
combined IL-1 and TNF infusion is significantly larger than 
the sum of the effects of IL-1 and TNF infusion separately. In 
the statistical analysis, first the areas under the curves (AUC) 
were calculated. These were corrected for pretreatment values 
(day -1  and/or 0) by subtracting the mean of the pretreat­
ment values from treatment values on each day (days 1-3). As 
it appears that the effect of TNF on the various parameters is 
directly proportional to the logarithm of the dose, we used the 
following linear regression model
AUC = aQ + c^ CIL-1) -I- ctjjdogTNF) + a3(IL-l) x log TNF
Here ao is an estimate of the effect of chronic administration of 
saline, a* is an estimate of the effect of continuous infusion of 
IL-1 alone, <*2 and c*2 + a;1 are estimates of the dose-response 
relationship for the effects of chronic infusion of TNF alone 
(0*2) or TNF in combination with IL-1 («2 + CX3). So, the 
coefficient a3 of the interaction term is an estimate for the 
synergism between IL-1 and TNF. Thus testing for a signifi­
cant dose-response relationship and/or synergism implies 
testing whether the corresponding ex’s are equal to zero. In 
case a significant dose-response relationship was found, Dun- 
nett’s ¿-test was performed to identify which dose of TNF 
induced a significant change in response compared with the
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RESULTS
TNF-free treatment group. Differences are considered as plasma ACTH levels. Infusion of IL-1 in combination 
statistically significant ifP was less than 0.05. with increasing doses of TNF (0.2, 2.0, or 10.0 fxg/day)
induced a dose-dependent increase in plasma ACTH 
levels compared with ACTH levels in animals infused 
with IL-1 alone, and a significant dose-response relation- 
Effects on plasma ACTH, B, and adrenal weight, ship was found with respect to the responses of plasma 
Figure 1 shows the effects of 3 days of continuous ACTH (AUC) in the four groups (P < 0.005). The effect 
infusion in rats with saline, IL-1 alone (2.0 |xg/day), of combined IL-1 and TNF infusion was synergistic 
TNF alone (0.2, 2.0, or 10.0 fxg/day), or 2.0 |xg IL-1 in (P < 0.05) compared with the effects of separate IL-1 
combination with 0.2, 2.0, or 10.0 |xg TNF/day on and TNF infusions. The highest ACTH levels were 
plasma levels of ACTH and B. The present experimental found on day 1 of infusion (IL-1: 132 ± 21  pg/ml; IL-1 
conditions (implantation of the minipump, infusion and and 0.2 |xg TNF/day: 187 ± 12 pg/ml; IL-1 and 2.0 fig 
blood collection procedures), as such, virtually did not TNF/day: 202 ± 29 pg/ml; IL-1 and 10.0 fxg TNF/day: 
alter pituitary-adrenal activity, as demonstrated by stable 204 ± 2 1  pg/ml). Plasma ACTH levels declined over 
plasma B levels in animals implanted with saline-filled days 2 and 3. Due to plasma shortage, plasma ACTH
osmotic pumps. levels of the saline-treated animals could not be mea-
Preinfusion levels of ACTH and B showed no marked sured.
differences between the various groups. ACTH preinfu- Plasma B levels were not significantly affected in rats
sion values varied between 89 and 137 pg/ml, and continuously infused with either IL-1 alone or TNF
preinfusion values of B varied between 24 and 64 alone (AUC, days 1-3)  compared with levels in saline-
nmol/1. Infusion of 2.0 |xg IL-l/day caused a small treated rats. Only a small increase in plasma B levels on
increase in plasma ACTH levels on the 1st day of day 1 of treatment with 2.0 |xg IL-l/day or with 10.0 (xg
infusion ( + 33 ± 14 pg/ml vs. day 0). Administration of TNF/day, compared with saline-treated animals, was
0.2, 2.0, or 10.0 |xg TNF/day did not significantly affect observed (IL-1: 130 ± 52 nmol/1; TNF: 104 ± 49 nmol/1;
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Fig. 1. Effects of 3 days continuous infusion in rata with saline, interleukin-1 (IL-1), or increasing doses of tumor 
necrosis factor (TNF) | left: salini» (o ), 2.0 |xg IL-l/day ( • ) ,  0.2 fxg TNF/day (I D, 2.0 (ig TNF/day (a), or 10.0 (xg 
TNF/day ( )| or IL-1 either alone or in combination with different doses of TNF \right; IL-1 (•), IL-1 with 0.2 jxg 
TNF/day (■), IL-1 with 2.0 (xg TNF/day (a ), or IL-1 with 10.0 |xg TNF/day (▼)I on plasma ACTII (topi and 
corticosterone (B; battam i levels. Blood samples were taken daily between 1000 and 1200. Osmotic minipumps were
between 14.*i() and 1630 on day 0 (arrow). Data are expressed as means -I- SE of 6-9 rats. Inset, corrected
areas under curves (AUC) for days 1 U. Left (separate IL-1 and TNF infusion): saline (a), 2.0 (xg IL-l/day (b), 0.2 |xg 
TNF/day (e), 2.0 jxg TNF/day (d), or 10.0 jxg TNF/day (e). Right (combined IL-1 and TNF infusion): IL-1 (b), IL-1 and
0.2 ixg TNF/day <f), IL-1 and 2.0 |xg TNF/day (g), or IL-1 and 10.0 |xg TNF/day (h). ACTH levels (including AUC) of 
saline-infused animals are missing due to plasma shortage. *P < 0.05 vs. IL-1 alone.
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saline: 31 ± 5 nmol/1). Infusion of IL-1 in combination 
with 0.2, 2.0, or 10.0 |xg TNF/day induced a dose- 
dependent increase in plasma B levels compared with 
the levels in animals infused with IL-1 alone; a signifi­
cant dose-response relationship was found with respect 
to the responses of plasma B (AUC) in the four groups 
(P < 0.0005). The effect of combined IL-1 and TNF 
infusion was synergistic (P < 0.0005) compared with 
the effects of separate IL-1 and TNF infusions. The 
highest B levels were measured on day 1 of infusion
(IL-1: 130 ± 52 nmol/1; IL-1 and 0.2 jxg TNF/day: 262 ± 
52 nmol/1; IL-1 and 2.0 |xg TNF/day: 355 ± 48 nmol/1; 
IL-1 and 10.0 (xg TNF/day: 415 ± 48 nmol/1). Like the 
plasma ACTH levels, plasma B levels decreased over 
days 2 and 3.
Total adrenal weight (summed weight of both adrenal 
glands) of rats treated for 3 days with 2.0 fig IL-1/day or 
with increasing doses of TNF alone did not significantly 
differ from total adrenal weight of rats infused with 
saline (40.1 ± 1.5 mg). Chronic infusion of rats with 
IL-1 in combination with 0.2, 2.0, or 10 |ig  TNF/day 
induced a dose-dependent increase in total adrenal 
weight compared with that of rats treated with IL-1 
alone. A significant dose-response relationship (P < 
0.0005) was found with respect to the effects on total 
adrenal weight in the four groups (IL-1: 39.1 ± 1.2 mg; 
IL-1 and 0.2 |xg TNF/day: 44.9 ± 1.4 mg, P < 0.05 vs. 
IL-1; IL-1 and 2.0 jig TNF/day: 45.2 ± 1.1 mg, P < 0.05 
vs. IL-1; IL-1 and 10.0 jig  TNF/day: 50.8 ± 1.9 mg, P <
0.05 vs. IL-1). The effect of combined IL-1 and TNF 
infusion was synergistic (P < 0.0005) compared with 
the effects of separate IL-1 and TNF infusions.
Effects on food and fluid intake and on body weight 
change. The effects of chronic administration of saline, 
IL-1 alone, TNF alone, and of IL-1 in combination with 
different doses of TNF on food and fluid intake and on 
body weight change are shown in Fig. 2. In saline- 
infused control rats, there was a slight reduction in both 
food (—4.6 ± 1.3 g) and fluid (—4.8 ± 1.4 ml) intake 1 
day after implantation of the pumps compared with day 
0. This decrease is probably due to the anesthesia on the 
day of implantation of the pumps. Chronic infusion of 
rats for 3 days with 2.0 jxg IL-1/day significantly 
reduced food intake (AUC, P < 0.05), whereas infusion 
of rats with increasing doses of TNF did not significantly 
affect food intake during the infusion period compared 
with saline treatment. Continuous administration of 
IL-1 in combination with 0.2, 2.0, or 10.0 ¡xg TNF/day 
induced a pronounced and dose-dependent decrease in 
food intake compared with food intake by rats infused 
with IL-1 alone, and a significant dose-response relation­
ship was found with respect to the effects on food intake 
(AUC) in the four groups (P < 0.0005). The effect of 
combined IL-1 and TNF infusion was synergistic (P < 
0.0005) compared with the effects of separate IL-1 and 
TNF infusions. Effects on food intake were maximal on 
days 1 -2  and were only partially restored on day 3.
2 5
Fig. 2. Effects of 3 days continuous adminis­
tration of saline, IL-1, or différent doses of 
TNF I left: saline (O), 2.0 |xg IL-l/day (•), 0.2 
\xg TNF/day (□), 2.0 tig TNF/day (a), or 10.0
(xg TNF/day (v)] or IL-1 either alone or in 
combination with increasing doses of TNF 
[right: IL-1 (•), IL-1 with 0.2 (xg TNF/day 
(■), IL-1 with 2.0 (tg TNF/day (a ),  or IL-1
'd*
(D
X<U
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5
with 10.0 |o,g TNF/day (▼)] on food and fluid 
intake (top and middle) and on daily body 
weight change {bottom). Food and fluid intake 
was estimated by weighing residual food pel­
lets and water for individual cages. Daily body 
weight change for each rat was calculated by 
subtraction of daily measured body weights 
(between 0815 and 0900) on subsequent days. 
Data are expressed as means + SE of 6-9 rats. 
Inset: corrected AUC for days 1-3. Left (sepa­
rate IL-1 and TNF infusion): saline (a), 2.0 |xg 
IL-l/day (b), 0.2 |xg TNF/day (c), 2.0 |xg 
TNF/day (d), or 10.0 |xg TNF/day (e). Right 
(combined IL-1 and TNF infusion): IL-1 (b), “ 
IL-1 and 0.2 (xg TNF/day (f), IL-1 and 2.0 ¡xg § 
TNF/day (g), or IL-1 and 10.0 jxg TNF/day |  
(h). 'YP < 0.05 vs. saline (left) and IL-1 (right).
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Fluid intake was not significantly affected by continu- TNF infusion was synergistic (P < 0.0005) compared
ous infusion of rats with 2.0 pig IL-1/day or with with the effects of separate IL-1 and TNF infusions,
increasing doses of TNF (0.2, 2.0, or 10.0 |xg/day) Rectal temperature returned to preinfusion values over
compared with fluid intake by saline-infused rats. Infu- days 2 - 3 . 
sion of IL-1 in combination with increasing doses of
TNF also did not significantly affect fluid intake of the DISCUSSION
animals compared with that of rats infused with IL-1 
alone. In the present study, it is demonstrated that continu-
There was a small decrease in body weight on the 1st ous intraperitoneal infusion of 0.2, 2.0, or 10.0 jxg
day of infusion of rats with 2.0 |xg IL-1/day or with 2.0 TNF/day had no significant effect on plasma ACTH and
or 10.0 |xg TNF/day compared with saline-infused rats. B levels and on adrenal weight and that chronic adminis-
Combined infusion of IL-1 and TNF induced a dose- tration of 2.0 jxg IL-1 /day induced only a slight increase
dependent weight loss of the animals compared with in plasma levels of ACTH and B on the 1st day of
infusion of rats with IL-1 alone, and a significant infusion. However, continuous infusion of IL-1 in combi-
dose-response relationship was found with respect to nation with increasing doses of TNF dose dependently
the effects on body weight change (AUC) in the four induced an increase in plasma levels of ACTH and B and
groups (P < 0.0005). The effect of combined IL-1 and total adrenal weight. Our results demonstrate that IL-1
TNF infusion was synergistic (P < 0.0005) compared (2.0 jxg/day) and TNF (0.2, 2.0, or 10.0 fxg/day) act
with the effects of separate IL-1 and TNF infusions. synergistically to increase plasma levels of ACTH and B
Effects on rectal temperature. Figure 3 shows the and total adrenal weight in rats.
effects of continuous infusion of saline, IL-1 alone 3 In line with our results, Perlstein et al. (19) recently
increasing doses of TNF alone, or of IL-1 in combination showed that simultaneous intraperitoneal bolus injec- 
with TNF on rectal temperature. Saline-infused rats tions of rhIL-la (10 ng) and rhTNF-a (1 jxg) in mice 
showed a small decrease in daily rectal temperature induced a response of plasma ACTH levels significantly
compared with preinfusion values. Chronic administra- greater than the sum of the ACTH responses to each
tion of IL-1 induced a significant increase (P < 0.0005) cytokine injected alone. These workers also demon-
in rectal temperature compared with saline infusion, strated that the synergistic effect of coinjection of
Continuous infusion of increasing doses of TNF (0.2, rhIL-la and rhTNF-a on plasma ACTH levels was
2.0, or 10.0 (xg/day) induced a dose-dependent ameliora- completely blocked by pretreatment of the mice with an
tion of the decrease in rectal temperature, as seen anti-IL-6 antibody, suggesting that these cytokines syn-
during saline infusion. A significant dose-response rela- ergistically induced IL-6 to produce the ACTH response,
tionship was found with respect to the effects of TNF on Indeed, Shalaby et al. (23) have shown that IL-1 and
rectal temperature (AUC) in the four groups (P < TNF act synergistically to stimulate IL-6 production in
0.005). Infusion of rats with IL-1 in combination with vivo. IL-1 and IL-6 also synergize to stimulate ACTH
TNF induced a dose-dependent increase in rectal tem- production; Perlstein et al. (18) showed that rhIL-la
perature compared with the increase in rectal tempera- and rhIL-6, when administered in suboptimal doses to
ture induced by infusion of IL-1 alone, and a significant mice, synergize to induce an early (30—60 min) response
dose-response relationship was found with respect to of ACTH, whereas a later (2-3 h) response was similar
the effects on rectal temperature (AUC) in the four to that observed after IL-1 administration alone. In
groups (P < 0.0005). The effect of combined IL-1 and contrast, synergism between IL-1 and TNF could not be
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Fig. 8. Effects of 3 days chronic administration of saline, IL-1, or different doses of TNF I left: saline (O ), 2.0 jxg 
IL-l/day (•), 0.2 jxg TNF day (I1), 2.0 |xg TNF/day (a), or 10.0 fig TNF/day (V)| or IL-1 either alone or in combination 
with increasing doses of TNF \ right: IL-1 (•), IL-1 with 0.2 jxg TNF/day (■), IL-1 with 2.0 |xg TNF/day ( a ), or IL-1
with 10.0 |xg TNF/day (▼)) on rectal temperature, Rectal temperature was calculated by averaging morning and 
afternoon rectal temperature. Each point represents mean ± SE of 6-9 rats. Inset: corrected AUC for days 1-3. Left 
(separate IL-1 and TNF infusion): saline (a), 2.0 |xg IL-l/day (b), 0.2 |xg TNF/day (c), 2.0 |xgTNF/day (d), or 10.0 |xg 
TNF/day (e). Right (combined IL-1 and TNF infusion): IL-1 (b), IL-1 and 0.2 |xg TNF/day (f), IL-1 and 2.0 |xg 
TNF/day (g), or IL-1 and 10.0 (xg TNF/day th). *P < 0.05 vs. saline {left) and IL-1 (right). **P < 0.0005 vs. saline.
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demonstrated by Gelin et al. (9), who showed in mice cantly, lowered the febrile response to IL-1. TNF itself
that the effect of intraperitoneal injections of rhIL-la in did not affect body temperature. However, it is difficult
combination with rhTNF-a on plasma B levels and on to compare our study with the study of Long et al. (13)
urinary B excretion was as great as the effect of twice because we studied rather long-term (1-3 days) effects
daily injections of rhIL-la alone. of continuous infusion of IL-1 and TNF on rectal
A common problem during infectious diseases is a temperature while Long et al. (13) studied short-term
decrease in appetite. This anorexia is probably a major (2-7 h) effects of acute coinjection of IL-1 and TNF on
cause of the body weight loss that occurs with infection, body core temperature.
IL-1 (11, 14, 28) and TNF (14, 25, 31) are peptides In summary, we demonstrated that continuous intra-
capable of inducing anorexia when administered in peritoneal infusion of rats with 0.2, 2.0, or 10.0 (xg
sufficient amounts. There is little known about the TNF/day for 3 days had no significant effect on plasma
effects of combined IL-1 and TNF infusion on food ACTH and B levels, whereas continuous infusion of 2.0
intake and body weight. The present study shows that |xg IL-l/day induced only a slight increase in plasma
chronic infusion of rats with IL-1 (2.0 |xg/day) signifi- ACTH and B levels on the 1st day of infusion. However,
cantly decreased food intake, whereas daily body weight simultaneous infusion of IL-1 with increasing doses of
change was not significantly affected. Chronic adminis- TNF stimulated the HPA axis in a dose-dependent and
tration of TNF in the doses used in our study (0.2,2.0, or synergistic way. Infusion of IL-1 alone significantly
10.0 jxg/day) had no significant effect on food consump- increased rectal temperature and decreased food intake,
tion and on daily body weight change. Continuous and infusion of the highest dose of TNF significantly
infusion of IL-1 in combination with TNF, however, increased rectal temperature compared with saline infu-
induced a very pronounced and dose-dependent suppres- sion. However, simultaneous infusion of IL-1 and TNF
sion of food intake and of body weight gain during the induced much greater changes in rectal temperature,
infusion period. These results are in line with observa- food consumption, and body weight change compared
tions by Gelin et al. (9), who demonstrated that twice with the effects of infusion of each cytokine alone,
daily combined injections (40 ng rhIL-la/day + 45 ng Although it is not fully established in what ways the
rhTNF-a/day) of mice resulted in a significant decrease apparent redundancy of the IL-1 and TNF systems
in food intake, whereas separate injections of rhIL-la benefit the organism, the existence of two pathways,
(40 ng/day) or rhTNF-a (450 ng/day, a dose 10 times which act synergistically, as clearly demonstrated m the
higher than in the combined injection) had no effect on present study, may indicate increased sensitivity of the
food intake.
Another activity of the cytokines IL-1 and TNF is
host to respond to subtle inflammatory stimuli (3).
We thank G. Grutters and H. Eikholt from the Central Animal
their ability to elevate body temperature. The effects of Laboratory for expert biotechnical assistance. A. Neppelenbroek 
acute administration of these cytokines on body tempera- Geerts and M. van der Wielen are acknowledged for measuring plasma 
ture are well documented (5). We confirm here that adrenocorticotropic hormone levels.
chronic infusion of 2.0 (xg IL-l/day or 10.0 fxg TNF/day 
for 3 days induces an increase in rectal temperature
This work was supported by the Royal Netherlands Academy of 
Arts and Sciences.
Address for reprint requests: M. J. M. van der Meer, Div. of
compared with saline-infused rats, whereas administra- Endocrinology, Dept, of Medicine, University Hospital Nijmegen,
tion of the lower doses of TNF (0.2 or 2.0 |Xg/day) had no Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.
significant effect on rectal temperature. This is in line Received 6 June 1994; accepted in final form 2 November 1994.
with previous studies from our laboratory in which it
was demonstrated that continuous infusion of 2.0 or 4.0 REFERENCES
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